-
1
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group
-
10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med 10:987-996
-
(2005)
N Engl J Med
, vol.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.6
-
2
-
-
0025096409
-
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity
-
2225314 10.1007/BF02994094 1:CAS:528:DyaK3MXhvFyqtLg%3D
-
Tsang LL, Farmer PB, Gescher A, Slack JA (1990) Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity. Cancer Chemother Pharmacol 26:429-436
-
(1990)
Cancer Chemother Pharmacol
, vol.26
, pp. 429-436
-
-
Tsang, L.L.1
Farmer, P.B.2
Gescher, A.3
Slack, J.A.4
-
3
-
-
0028133013
-
NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA
-
8049205 10.1021/bi00197a003 1:CAS:528:DyaK2cXkvF2hsbs%3D
-
Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, Slack JA (1994) NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33:9045-9051
-
(1994)
Biochemistry
, vol.33
, pp. 9045-9051
-
-
Denny, B.J.1
Wheelhouse, R.T.2
Stevens, M.F.3
Tsang, L.L.4
Slack, J.A.5
-
4
-
-
0026750738
-
Self-destruction and tolerance in resistance of mammalian cells to alkylation damage
-
1620587 10.1093/nar/20.12.2933 1:CAS:528:DyaK38XltVensL4%3D
-
Karran P, Bignami M (1992) Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res 20:2933-2940
-
(1992)
Nucleic Acids Res
, vol.20
, pp. 2933-2940
-
-
Karran, P.1
Bignami, M.2
-
5
-
-
1942469956
-
MGMT: Its role in cancer aetiology and cancer therapeutics
-
15057289 10.1038/nrc1319 1:CAS:528:DC%2BD2cXis1Gmt70%3D
-
Gerson SL (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4:296-307
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 296-307
-
-
Gerson, S.L.1
-
6
-
-
0030611736
-
Understanding and manipulating O6-methylguanine-DNA methyltransferase expression
-
9352585 10.1016/S0163-7258(97)00003-X 1:CAS:528:DyaK2sXmsFCgs7c%3D
-
Pieper RO (1997) Understanding and manipulating O6-methylguanine-DNA methyltransferase expression. Pharmacol Ther 74:285-297
-
(1997)
Pharmacol Ther
, vol.74
, pp. 285-297
-
-
Pieper, R.O.1
-
7
-
-
0020332947
-
Mismatch correction at O6-methylguanine residues in E coli DNA
-
7040986 10.1038/296868a0 1:CAS:528:DyaL38Xks1Oiu78%3D
-
Karran P, Marinus MG (1982) Mismatch correction at O6-methylguanine residues in E. coli DNA. Nature 296:868-869
-
(1982)
Nature
, vol.296
, pp. 868-869
-
-
Karran, P.1
Marinus, M.G.2
-
8
-
-
0043290038
-
DNA repair and tumorigenesis: Lessons from hereditary cancer syndromes
-
12496472
-
Heinen CD, Schmutte C, Fishel R (2002) DNA repair and tumorigenesis: lessons from hereditary cancer syndromes. Cancer Biol Ther 1:477-485
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 477-485
-
-
Heinen, C.D.1
Schmutte, C.2
Fishel, R.3
-
9
-
-
0027292234
-
An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair
-
8341649 10.1073/pnas.90.14.6424 1:CAS:528:DyaK3sXlvFGhs74%3D
-
Kat A, Thilly WG, Fang WH, Longley MJ, Li GM, Modrich P (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA 90:6424-6428
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 6424-6428
-
-
Kat, A.1
Thilly, W.G.2
Fang, W.H.3
Longley, M.J.4
Li, G.M.5
Modrich, P.6
-
10
-
-
0035266245
-
P53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells
-
11280752 1:CAS:528:DC%2BD3MXit1Ogsrk%3D
-
Hirose Y, Berger MS, Pieper RO (2001) p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61:1957-1963
-
(2001)
Cancer Res
, vol.61
, pp. 1957-1963
-
-
Hirose, Y.1
Berger, M.S.2
Pieper, R.O.3
-
11
-
-
0030665150
-
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells
-
9371520 1:CAS:528:DyaK2sXnsV2kur4%3D
-
Poon RY, Chau MS, Yamashita K, Hunter T (1997) The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 57:5168-5178
-
(1997)
Cancer Res
, vol.57
, pp. 5168-5178
-
-
Poon, R.Y.1
Chau, M.S.2
Yamashita, K.3
Hunter, T.4
-
12
-
-
0036847320
-
Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability
-
12411508 10.1093/emboj/cdf567 1:CAS:528:DC%2BD38XosVSrt7g%3D
-
Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J (2002) Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 21:5911-5920
-
(2002)
EMBO J
, vol.21
, pp. 5911-5920
-
-
Mailand, N.1
Podtelejnikov, A.V.2
Groth, A.3
Mann, M.4
Bartek, J.5
Lukas, J.6
-
13
-
-
0033695002
-
Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C
-
11063929 10.1016/S0955-0674(00)00149-6 1:CAS:528:DC%2BD3cXovVags7c%3D
-
Takizawa CG, Morgan DO (2000) Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. Curr Opin Cell Biol 12:658-665
-
(2000)
Curr Opin Cell Biol
, vol.12
, pp. 658-665
-
-
Takizawa, C.G.1
Morgan, D.O.2
-
14
-
-
0032484084
-
Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
-
9836640 10.1126/science.282.5395.1893 1:CAS:528:DyaK1cXotVWitrw%3D
-
Matsuoka S, Huang M, Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893-1897
-
(1998)
Science
, vol.282
, pp. 1893-1897
-
-
Matsuoka, S.1
Huang, M.2
Elledge, S.J.3
-
15
-
-
0030867582
-
Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25
-
9278511 10.1126/science.277.5331.1497 1:CAS:528:DyaK2sXlvVGltbc%3D
-
Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H et al (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501
-
(1997)
Science
, vol.277
, pp. 1497-1501
-
-
Sanchez, Y.1
Wong, C.2
Thoma, R.S.3
Richman, R.4
Wu, Z.5
Piwnica-Worms, H.6
-
16
-
-
0035422203
-
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells
-
11479224 1:CAS:528:DC%2BD3MXlvVCguro%3D
-
Hirose Y, Berger MS, Pieper RO (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61:5843-5849
-
(2001)
Cancer Res
, vol.61
, pp. 5843-5849
-
-
Hirose, Y.1
Berger, M.S.2
Pieper, R.O.3
-
18
-
-
19644373959
-
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence
-
15930307 10.1158/0008-5472.CAN-04-2633 1:CAS:528:DC%2BD2MXks1Ohu70%3D
-
Hirose Y, Katayama M, Mirzoeva OK, Berger MS, Pieper RO (2005) Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res 65:4861-4869
-
(2005)
Cancer Res
, vol.65
, pp. 4861-4869
-
-
Hirose, Y.1
Katayama, M.2
Mirzoeva, O.K.3
Berger, M.S.4
Pieper, R.O.5
-
19
-
-
2442689169
-
Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide
-
15200121 10.3171/jns.2004.100.6.1060 1:CAS:528:DC%2BD2cXltlCrtb0%3D
-
Hirose Y, Katayama M, Berger MS, Pieper RO (2004) Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide. J Neurosurg 100:1060-1065
-
(2004)
J Neurosurg
, vol.100
, pp. 1060-1065
-
-
Hirose, Y.1
Katayama, M.2
Berger, M.S.3
Pieper, R.O.4
-
20
-
-
0034020459
-
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
-
10802656 10.1038/75596 1:CAS:528:DC%2BD3cXjtFSltro%3D
-
Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55-57
-
(2000)
Nat Genet
, vol.25
, pp. 55-57
-
-
Holland, E.C.1
Celestino, J.2
Dai, C.3
Schaefer, L.4
Sawaya, R.E.5
Fuller, G.N.6
-
21
-
-
0036841293
-
Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage
-
12391152 10.1128/MCB.22.22.7831-7841.2002 1:CAS:528:DC%2BD38XotlCgs7s%3D
-
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS et al (2002) Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22:7831-7841
-
(2002)
Mol Cell Biol
, vol.22
, pp. 7831-7841
-
-
Kandel, E.S.1
Skeen, J.2
Majewski, N.3
Di Cristofano, A.4
Pandolfi, P.P.5
Feliciano, C.S.6
-
22
-
-
0037018847
-
A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle
-
12062056 10.1016/S0960-9822(02)00843-6 1:CAS:528:DC%2BD38XksFOjtb4%3D
-
Shtivelman E, Sussman J, Stokoe D (2002) A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 12:919-924
-
(2002)
Curr Biol
, vol.12
, pp. 919-924
-
-
Shtivelman, E.1
Sussman, J.2
Stokoe, D.3
-
23
-
-
17144436629
-
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
-
9090379 10.1038/ng0497-356 1:CAS:528:DyaK2sXitF2hs70%3D
-
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362
-
(1997)
Nat Genet
, vol.15
, pp. 356-362
-
-
Steck, P.A.1
Pershouse, M.A.2
Jasser, S.A.3
Yung, W.K.4
Lin, H.5
Ligon, A.H.6
-
24
-
-
3042823868
-
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
-
15143086 10.1200/JCO.2004.07.193 1:CAS:528:DC%2BD2cXptlCksrY%3D
-
Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A et al (2004) The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22:1926-1933
-
(2004)
J Clin Oncol
, vol.22
, pp. 1926-1933
-
-
Chakravarti, A.1
Zhai, G.2
Suzuki, Y.3
Sarkesh, S.4
Black, P.M.5
Muzikansky, A.6
-
25
-
-
0036094711
-
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival
-
12006525 1:CAS:528:DC%2BD38XksVSqu7o%3D
-
Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR et al (2002) Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8:1100-1106
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1100-1106
-
-
Ermoian, R.P.1
Furniss, C.S.2
Lamborn, K.R.3
Basila, D.4
Berger, M.S.5
Gottschalk, A.R.6
-
26
-
-
0035909313
-
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
-
11607034 10.1038/35099574 1:CAS:528:DC%2BD3MXnvFemu7g%3D
-
Alvarez B, Martínez-A C, Burgering BM, Carrera AC (2001) Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 413:744-777
-
(2001)
Nature
, vol.413
, pp. 744-777
-
-
Alvarez, B.1
Martínez-A, C.2
Burgering, B.M.3
Carrera, A.C.4
-
27
-
-
0347988005
-
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3 K-Akt signaling through downregulation of PDGFR
-
14561707 1:CAS:528:DC%2BD3sXotlWisL4%3D
-
Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N et al (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3 K-Akt signaling through downregulation of PDGFR. J Clin Invest 112:1223-1233
-
(2003)
J Clin Invest
, vol.112
, pp. 1223-1233
-
-
Zhang, H.1
Cicchetti, G.2
Onda, H.3
Koon, H.B.4
Asrican, K.5
Bajraszewski, N.6
-
28
-
-
0348075994
-
Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells
-
12813134 1:CAS:528:DC%2BD3sXlslWkt7Y%3D
-
Motwani M, Rizzo C, Sirotnak F, She Y, Schwartz GK (2003) Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. Mol Cancer Ther 2:549-555
-
(2003)
Mol Cancer Ther
, vol.2
, pp. 549-555
-
-
Motwani, M.1
Rizzo, C.2
Sirotnak, F.3
She, Y.4
Schwartz, G.K.5
-
29
-
-
42449139803
-
Flavopiridolsuppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells
-
18287248 10.1124/mol.107.041350 1:CAS:528:DC%2BD1cXlsVWgu7k%3D
-
Takada Y, Sethi G, Sung B, Aggarwal BB (2008) Flavopiridolsuppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells. Mol Pharmacol 73:1549-1557
-
(2008)
Mol Pharmacol
, vol.73
, pp. 1549-1557
-
-
Takada, Y.1
Sethi, G.2
Sung, B.3
Aggarwal, B.B.4
-
30
-
-
20244362748
-
Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis
-
12517783 1:CAS:528:DC%2BD3sXjvFKlsw%3D%3D
-
Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H et al (2003) Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res 63:93-99
-
(2003)
Cancer Res
, vol.63
, pp. 93-99
-
-
Wittmann, S.1
Bali, P.2
Donapaty, S.3
Nimmanapalli, R.4
Guo, F.5
Yamaguchi, H.6
-
31
-
-
0035884505
-
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma
-
11559533 1:CAS:528:DC%2BD3MXntFais74%3D
-
Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674-6678
-
(2001)
Cancer Res
, vol.61
, pp. 6674-6678
-
-
Sonoda, Y.1
Ozawa, T.2
Aldape, K.D.3
Deen, D.F.4
Berger, M.S.5
Pieper, R.O.6
-
32
-
-
0032496239
-
Construction and characterization of a conditionally active version of the serine/threonine kinase Akt
-
9565622 10.1074/jbc.273.19.11937 1:CAS:528:DyaK1cXjt1agt7k%3D
-
Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA et al (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273:11937-11943
-
(1998)
J Biol Chem
, vol.273
, pp. 11937-11943
-
-
Kohn, A.D.1
Barthel, A.2
Kovacina, K.S.3
Boge, A.4
Wallach, B.5
Summers, S.A.6
-
33
-
-
0029810181
-
Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation
-
8702995 10.1074/jbc.271.36.21920 1:CAS:528:DyaK28XlsFKgu70%3D
-
Kohn AD, Takeuchi F, Roth RA (1996) Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 271:21920-21926
-
(1996)
J Biol Chem
, vol.271
, pp. 21920-21926
-
-
Kohn, A.D.1
Takeuchi, F.2
Roth, R.A.3
-
34
-
-
0034749425
-
DNA damage-dependent nuclear dynamics of the Mre11 complex
-
11113202 10.1128/MCB.21.1.281-288.2001 1:CAS:528:DC%2BD3MXptVSj
-
Mirzoeva OK, Petrini JH (2001) DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol 21:281-288
-
(2001)
Mol Cell Biol
, vol.21
, pp. 281-288
-
-
Mirzoeva, O.K.1
Petrini, J.H.2
-
35
-
-
0037365825
-
Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity
-
12650433 10.3171/jns.2003.98.3.0591 1:CAS:528:DC%2BD3sXitleitLg%3D
-
Hirose Y, Kreklau EL, Erickson LC, Berger MS, Pieper RO (2003) Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. J Neurosurg 98:591-598
-
(2003)
J Neurosurg
, vol.98
, pp. 591-598
-
-
Hirose, Y.1
Kreklau, E.L.2
Erickson, L.C.3
Berger, M.S.4
Pieper, R.O.5
-
36
-
-
0035872396
-
Disruption of the EF-2 kinase/Hsp90 protein complex: A possible mechanism to inhibit glioblastoma by geldanamycin
-
11358819 1:CAS:528:DC%2BD3MXktVWqsbs%3D
-
Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, Hait WN (2001) Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res 61:4010-4016
-
(2001)
Cancer Res
, vol.61
, pp. 4010-4016
-
-
Yang, J.1
Yang, J.M.2
Iannone, M.3
Shih, W.J.4
Lin, Y.5
Hait, W.N.6
-
37
-
-
74549116355
-
Targeting Polo-like kinase in cancer therapy
-
20068088 10.1158/1078-0432.CCR-09-1380 1:CAS:528:DC%2BC3cXktF2qsbw%3D
-
Degenhardt Y, Lampkin T (2010) Targeting Polo-like kinase in cancer therapy. Clin Cancer Res 16:384-389
-
(2010)
Clin Cancer Res
, vol.16
, pp. 384-389
-
-
Degenhardt, Y.1
Lampkin, T.2
-
38
-
-
0035252654
-
Chromosomal passengers and the (aurora) ABCs of mitosis
-
11166196 10.1016/S0962-8924(00)01880-8 1:CAS:528:DC%2BD3MXpslyksg%3D%3D
-
Adams RR, Carmena M, Earnshaw WC (2001) Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 11:49-54
-
(2001)
Trends Cell Biol
, vol.11
, pp. 49-54
-
-
Adams, R.R.1
Carmena, M.2
Earnshaw, W.C.3
-
39
-
-
0342657718
-
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
-
10850418 1:CAS:528:DC%2BD3cXjvFOlsLo%3D
-
Olie RA, Simões-Wüst AP, Baumann B, Leech SH, Fabbro D, Stahel RA et al (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805-2809
-
(2000)
Cancer Res
, vol.60
, pp. 2805-2809
-
-
Olie, R.A.1
Simões-Wüst, A.P.2
Baumann, B.3
Leech, S.H.4
Fabbro, D.5
Stahel, R.A.6
-
40
-
-
22144448593
-
Histone H2A phosphorylation in DNA double-strand break repair
-
15978030 10.1111/j.1742-4658.2005.04741.x 1:CAS:528:DC%2BD2MXmtFKrtLY%3D
-
Foster ER, Downs JA (2005) Histone H2A phosphorylation in DNA double-strand break repair. FEBS J 272:3231-3240
-
(2005)
FEBS J
, vol.272
, pp. 3231-3240
-
-
Foster, E.R.1
Downs, J.A.2
-
41
-
-
17144385867
-
Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: An atypical tyrosine kinase with a key role in CDK1 regulation
-
15837193 10.1016/j.str.2004.12.017 1:CAS:528:DC%2BD2MXjtlamt70%3D
-
Squire CJ, Dickson JM, Ivanovic I, Baker EN (2005) Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation. Structure 13:541-550
-
(2005)
Structure
, vol.13
, pp. 541-550
-
-
Squire, C.J.1
Dickson, J.M.2
Ivanovic, I.3
Baker, E.N.4
-
42
-
-
39249085477
-
Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1
-
18234299 10.1016/j.ygyno.2007.11.007 1:CAS:528:DC%2BD1cXitlCjtrY%3D
-
Hoekstra AV, Ward EC, Hardt JL, Lurain JR, Singh DK, Buttin BM, Schink JC, Kim JJ (2008) Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol Oncol 108:609-618
-
(2008)
Gynecol Oncol
, vol.108
, pp. 609-618
-
-
Hoekstra, A.V.1
Ward, E.C.2
Hardt, J.L.3
Lurain, J.R.4
Singh, D.K.5
Buttin, B.M.6
Schink, J.C.7
Kim, J.J.8
-
43
-
-
0037228959
-
Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis
-
12517802 1:CAS:528:DC%2BD3sXjvFKnsQ%3D%3D
-
Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC (2003) Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res 63:230-235
-
(2003)
Cancer Res
, vol.63
, pp. 230-235
-
-
Wall, N.R.1
O'Connor, D.S.2
Plescia, J.3
Pommier, Y.4
Altieri, D.C.5
-
44
-
-
84865680221
-
The Mayo Phase 2 Consortium (P2C) and North Central Cancer Treatment Group (NCCTG). A phase 2 trial of flavopiridol (alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261
-
22664059 10.1016/j.ygyno.2012.05.030 1:CAS:528:DC%2BC38XptFagsb8%3D
-
Bible KC, Peethambaram PP, Oberg AL, Maples W, Groteluschen DL, Boente M et al (2012) the Mayo Phase 2 Consortium (P2C) and North Central Cancer Treatment Group (NCCTG). A phase 2 trial of flavopiridol (alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261. Gynecol Oncol 127(1):55-62
-
(2012)
Gynecol Oncol
, vol.127
, Issue.1
, pp. 55-62
-
-
Bible, K.C.1
Peethambaram, P.P.2
Oberg, A.L.3
Maples, W.4
Groteluschen, D.L.5
Boente, M.6
-
45
-
-
79956036001
-
Phase i trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms
-
21447728 10.1158/1078-0432.CCR-10-2876 1:CAS:528:DC%2BC3MXmtVGit7g%3D
-
Holkova B, Perkins EB, Ramakrishnan V, Tombes MB, Shrader E, Talreja N et al (2011) Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms. Clin Cancer Res 17:3388-3397
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3388-3397
-
-
Holkova, B.1
Perkins, E.B.2
Ramakrishnan, V.3
Tombes, M.B.4
Shrader, E.5
Talreja, N.6
-
46
-
-
0034597571
-
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: Synthesis and biological effects
-
11063609 10.1021/jm000231g 1:CAS:528:DC%2BD3cXnt1OisL8%3D
-
Kim KS, Sack JS, Tokarski JS, Qian L, Chao ST, Leith L et al (2000) Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J Med Chem 43:4126-4134
-
(2000)
J Med Chem
, vol.43
, pp. 4126-4134
-
-
Kim, K.S.1
Sack, J.S.2
Tokarski, J.S.3
Qian, L.4
Chao, S.T.5
Leith, L.6
-
47
-
-
23044508121
-
Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas
-
15970925 10.1038/sj.bjc.6602661
-
Bäcklund LM, Nilsson BR, Liu L, Ichimura K, Collins VP (2005) Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas. Br J Cancer 93:124-130
-
(2005)
Br J Cancer
, vol.93
, pp. 124-130
-
-
Bäcklund, L.M.1
Nilsson, B.R.2
Liu, L.3
Ichimura, K.4
Collins, V.P.5
-
48
-
-
0028117269
-
Analysis of the p53 gene and its expression in human glioblastoma cells
-
8306326
-
Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE et al (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649-652
-
(1994)
Cancer Res
, vol.54
, pp. 649-652
-
-
Van Meir, E.G.1
Kikuchi, T.2
Tada, M.3
Li, H.4
Diserens, A.C.5
Wojcik, B.E.6
-
49
-
-
0030917734
-
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies
-
9815715 1:CAS:528:DyaK2sXislGitLY%3D
-
Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N et al (1997) Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 3:523-530
-
(1997)
Clin Cancer Res
, vol.3
, pp. 523-530
-
-
Watanabe, K.1
Sato, K.2
Biernat, W.3
Tachibana, O.4
Von Ammon, K.5
Ogata, N.6
-
50
-
-
45749098900
-
AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition
-
18413665 10.1124/mol.107.044743 1:CAS:528:DC%2BD1cXot1aksbk%3D
-
Caporali S, Levati L, Starace G, Ragone G, Bonmassar E, Alvino E et al (2008) AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. Mol Pharmacol 74:173-183
-
(2008)
Mol Pharmacol
, vol.74
, pp. 173-183
-
-
Caporali, S.1
Levati, L.2
Starace, G.3
Ragone, G.4
Bonmassar, E.5
Alvino, E.6
-
51
-
-
84858719382
-
Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development
-
22391209 10.4161/cc.11.6.19663 1:CAS:528:DC%2BC38XmslWntb0%3D
-
Caracciolo V, Laurenti G, Romano G, Carnevale V, Cimini AM, Crozier-Fitzgerald C et al (2012) Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: implications for drug design and development. Cell Cycle 11:1202-1216
-
(2012)
Cell Cycle
, vol.11
, pp. 1202-1216
-
-
Caracciolo, V.1
Laurenti, G.2
Romano, G.3
Carnevale, V.4
Cimini, A.M.5
Crozier-Fitzgerald, C.6
|